BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10896494)

  • 1. Comorbidity of keratosis follicularis (Darier's Disease) and bipolar affective disorder: an indication for valproate instead of lithium.
    Ehrt U; Brieger P
    Gen Hosp Psychiatry; 2000; 22(2):128-9. PubMed ID: 10896494
    [No Abstract]   [Full Text] [Related]  

  • 2. Darier's disease associated with bipolar affective disorder: a case report.
    Wang SL; Yang SF; Chen CC; Tsai PT; Chai CY
    Kaohsiung J Med Sci; 2002 Dec; 18(12):622-6. PubMed ID: 12670038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium neurotoxicity at normal serum levels.
    Mesquita J; Cepa S; Silva L; Machado A
    J Neuropsychiatry Clin Neurosci; 2010; 22(4):451-p.e29-451.e29. PubMed ID: 21037148
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease.
    Jones I; Jacobsen N; Green EK; Elvidge GP; Owen MJ; Craddock N
    Mol Psychiatry; 2002; 7(4):424-7. PubMed ID: 11986988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T; Kroger H; Pikalov A; Loebel A
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for the pharmacotherapy of bipolar disorder.
    Motohashi N
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S41-4. PubMed ID: 10560897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapyramidal syndrome due to valproate administration as an adjunct to lithium in an elderly manic patient.
    Wils V; Golüke-Willemse G
    Int J Geriatr Psychiatry; 1997 Feb; 12(2):272. PubMed ID: 9097225
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamotrigine use in geriatric patients with bipolar depression.
    Robillard M; Conn DK
    Can J Psychiatry; 2002 Oct; 47(8):767-70. PubMed ID: 12420655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial cosegregation of major affective disorder and Darier's disease (keratosis follicularis).
    Craddock N; Owen M; Burge S; Kurian B; Thomas P; McGuffin P
    Br J Psychiatry; 1994 Mar; 164(3):355-8. PubMed ID: 8199789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 Cases.
    Rosso G; Solia F; Albert U; Maina G
    J Clin Psychopharmacol; 2017 Apr; 37(2):278-281. PubMed ID: 28129310
    [No Abstract]   [Full Text] [Related]  

  • 14. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal dosing of medications (in bipolar disorder).
    Maguire GA; Phillips G
    J Fam Pract; 2003 Mar; Suppl():S22-5. PubMed ID: 12676081
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.